BLOOD-LEVELS AND SERUM-PROTEIN BINDING OF CIS-PLATINUM(II) COMPLEXED TO CARBOXYMETHYL-DEXTRAN

被引：27

作者：

SCHECHTER, B

ROSING, MA

WILCHEK, M

ARNON, R

机构：

[1] WEIZMANN INST SCI,DEPT CHEM IMMUNOL,IL-76100 REHOVOT,ISRAEL

[2] WEIZMANN INST SCI,DEPT BIOPHYS,IL-76100 REHOVOT,ISRAEL

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1989年 / 24卷 / 03期

关键词：

D O I：

10.1007/BF00300236

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：161 / 166

页数：6

共 20 条

[1]

ALTMAN PL, 1964, BIOL DATA BOOK, P263

[2]

BELT RJ, 1979, CANCER TREAT REP, V63, P1515

[3]

DECONTI RC, 1973, CLIN PHARM STUDIES C

[4] ACUTE AND LONG-TERM NEPHROTOXICITY OF CISPLATINUM IN MAN [J].

GROTH, S ;

NIELSEN, H ;

SORENSEN, JB ;

CHRISTENSEN, AB ;

PEDERSEN, AG ;

RORTH, M .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 17 (02) :191-196

[5] PHARMACOKINETICS AND PROTEIN-BINDING OF CIS-DICHLORODIAMMINE PLATINUM (II) ADMINISTERED AS A ONE-HOUR OR AS A 20-HOUR INFUSION [J].

GULLO, JJ ;

LITTERST, CL ;

MAGUIRE, PJ ;

SIKIC, BI ;

HOTH, DF ;

WOOLLEY, PV .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 5 (01) :21-26

[6]

HARLAND SJ, 1984, CANCER RES, V44, P1693

[7] EFFECT OF MANNITOL AND PLASMA ON THE CYTO-TOXICITY OF CISPLATIN [J].

HOLDENER, EE ;

PARK, CH ;

BELT, RJ ;

STEPHENS, RL ;

HOOGSTRATEN, B .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (04) :515-518

[8]

HOWELL SB, 1983, CANCER RES, V43, P1426

[9]

HURWITZ E, 1980, J APPL BIOCHEM, V2, P125

[10]

LITTERST CL, 1976, CANCER RES, V36, P2340

← 1 2 →